1
|
Dolzhenko MM, Barnett OY, Grassos C, Dragomiretska NV, Goloborodko BI, Ilashchuk TO, Zuiev KO, Karpenko OV, Kolesnikova OV, Kolesnyk TV, Talaieva TV, Vakaliuk IP, Tiabut TD, Mesnikova IL, Zinych OV. Management of Dyslipidemia in Individuals with Low-to-Moderate Cardiovascular Risk: Role of Nutraceuticals. Adv Ther 2020; 37:4549-4567. [PMID: 32979190 DOI: 10.1007/s12325-020-01490-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2020] [Indexed: 02/08/2023]
Abstract
Cardiovascular diseases (CVDs) are the leading cause of premature deaths globally and in Ukraine. Dyslipidemia is a recognized risk factor for the development of CVD. Therefore, early detection and appropriate management of dyslipidemia are essential for the primary prevention of CVDs. However, currently, there is a lack of Ukraine-specific guideline recommendations focusing on the management of dyslipidemia in individuals with low-to-moderate CV risk, thus creating an urgent need for structured and easily implementable clinical recommendations/guidelines specific to the country. An expert panel of cardiologists, endocrinologists, and family physicians convened in Ukraine in March 2019. The expert panel critically reviewed and analyzed the current literature and put forth the following recommendations for the management of dyslipidemia in individuals with low-to-moderate risk of CVDs specific to Ukraine: (1) family physicians have the greatest opportunities in carrying out primary prevention; (2) lipid-lowering interventions are essential for primary prevention as per guidelines; (3) a number of nutraceuticals and nutraceutical combinations with clinically established lipid-lowering properties can be considered for primary prevention; they also have a suggested role as an alternative therapy for statin-intolerant patients; (4) on the basis of clinical evidence, nutraceuticals are suggested by guidelines for primary prevention; (5) red yeast rice has potent CV-risk-lowering potential, in addition to lipid-lowering properties; (6) in patients with low-to-moderate cardiovascular risk, a nutraceutical combination of low-dose red yeast rice and synergic lipid-lowering compounds can be used as integral part of guideline-recommended lifestyle interventions for effective primary prevention strategy; (7) nutraceutical combination can be used in patients aged 18 to 75+ years; its use is particularly appropriate in the age group of 18-44 years; (8) it is necessary to attract the media (websites, etc.) to increase patient awareness on the importance of primary prevention; and (9) it is necessary to legally separate nutraceuticals from dietary supplements. These consensus recommendations will help physicians in Ukraine effectively manage dyslipidemia in individuals with low-to-moderate CV risk.
Collapse
Affiliation(s)
- Maryna Mykolaivna Dolzhenko
- The Cardiology Department, The Shupyk National Medical Academy of Postgraduate Education, Dorogozhytska St., 9, Kyiv, 04112, Ukraine.
| | - Olga Yulianivna Barnett
- Department of Therapy № 1 of Medical Diagnostics, Hematology and Transfusiology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
| | - Charalampos Grassos
- The Cardiology Department, General Hospital of Attica "KAT", Kifissia, Greece
| | - Natalia Volodymirivna Dragomiretska
- The Medical Rehabilitation Department, SI "Ukrainian Scientific-Research Institute of Medical Rehabilitation and Balneology of the Ministry of Health of Ukraine", Kiev, Ukraine
| | | | - Tetiana Oleksandrivna Ilashchuk
- The Propedeutics of Internal Diseases Department, Higher State Educational Establishment of Ukraine "Bukovinian State Medical University", Chernivtsi, Ukraine
| | | | | | - Olena Vadymivna Kolesnikova
- Aging and the Metabolic Associated Diseases Prevention Research Department, Government Institution "L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine", Kharkiv, Ukraine
| | - Tetiana Volodymirivna Kolesnyk
- The Department of Internal Medicine Propedeutics, State Institution "Dnipropetrovsk Medical Academy" of the Ministry of Health of Ukraine, Dnipro, Ukraine
| | - Tetyana Volodymirivna Talaieva
- The Department of Clinical Physiology and Genetics, National Scientific Center, M.D. Strazhesko Institute of Cardiology, Kiev, Ukraine
| | - Igor Petrovych Vakaliuk
- The Department of Internal Medicine No. 2 and Nursing, State Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
| | - Tamara Dmitrievna Tiabut
- The Cardiology and Rheumatology Department, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus
| | | | - Olesia Vadymivna Zinych
- The Age Endocrinology and Clinical Pharmacology Department, State Institution V.P. Komisarenko Institute of Endocrinology and Metabolism of NAMS of Ukraine, Kiev, Ukraine
| |
Collapse
|
2
|
Oinotkinova OS, Nikonov EL, Kryukov EV, Baranov AP, Voevoda MI. Evolution of dyslipidemia: from etiological mechanisms to new targets of personalized preventive nutraceutical therapy with red yeast rice. ACTA ACUST UNITED AC 2019. [DOI: 10.15829/1728-8800-2019-6-88-98] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- O. Sh. Oinotkinova
- Moscow State University; Research Institute of Public Health and Healthcare Management
| | - E. L. Nikonov
- Pirogov Russian National Research Medical University
| | | | - A. P. Baranov
- Moscow State University; Pirogov Russian National Research Medical University
| | - M. I. Voevoda
- Research Center for Fundamental and Translational Medicine
| |
Collapse
|